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ABSTRACT 
 
Diabetes is a serious health concern all over the world. Among people with diabetes, a key factor influencing 
quality of life (QOL) is degree and nature of diabetes related complications experienced by the patients over 
a lifetime. QOL is important health related factor and one of the most widely used measure to self-assess the 
effect of the management of chronic disease on health and monitors the physical, psychological, and social 
aspects of personal health. This study is a prospective questionnaire based observational study which was 
conducted in a tertiary care hospital among diabetic patients using WHOQOL-BREF questionnaire and rele-
vant information was collected. The domain wise scores are calculated. A total of 140 diabetic patients were 
included in the study of which 100 were with complications and 40 were without complications. The infer-
ence obtained this study was that nephropathy is the most common microvascular complication and affects 
the psychological and environmental status of subjects. We conclude that taking proper diabetic diet and 
self-care can prevent the worsening of QOL in patients with microvascular complications. 
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INTRODUCTION 
The WHO defined “Diabetes mellitus as a group of 
metabolic disorders characterized by hyperglycemia, 
is associated with abnormalities in carbohydrate, fat 
and protein metabolism and results in chronic com-
plications including microvascular and macrovascu-
lar complications”.  
Diabetes mellitus is classified into two types. They are 
type 1 (insulin dependent) and type 2 (combination 
of insulin resistance and reduced insulin secretion). 
Type 1 is an autoimmune disease characterized by 
pancreatic beta cell destruction and an absolute defi-
ciency of insulin. It accounts for approximately 5 to 
10% of all cases, most commonly diagnosed in pa-
tients younger than 20 years of age. 
Type 2 is caused by a combination of peripheral re-
sistance to insulin action and a reduced secretory re-
sponse by the beta cells of pancreas. It accounts for 
approximately 90 to 95% of diabetic patients and a 
vast majority of such patients are overweight. The 
prevalence of type 2 diabetes in children and adoles-
cents is increasing at an alarming pace.[1] 
Diabetes is the main cause for serious complications 
like cardiovascular diseases, cerebrovascular dis-
eases, renal disorders inflammation and immunity, 
and obesity.[2] Factors which affect diabetes compli-
cations are gender, age, and ethnic background. De-
fects in insulin metabolism and dysfunction in carbo-
hydrate, lipid and protein metabolism leads to high 
levels of blood glucose which result in long term com-
plications.[3] These complications affect small blood 
vessels that typically includes retinopathy, neuropa-
thy , nephropathy . 
Diabetic Retinopathy is progressive chronic disease 
that results from vascular injury due to hypoglyce-
mia, which is the leading cause of blindness in work-
ing age adults.[4]  
Diabetic nephropathy is a progressive rise in urine al-
bumin excretion, coupled with increasing blood pres-
sure, leading to declining glomerular filtration and 
eventually results in end stage renal failure. [5] 
Diabetic Neuropathy is a heterogeneous condition re-
lated to nerve pathology, the condition is classified 
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according to the nerves affected and include focal, dif-
fuse, sensory, and autonomic.[4] 
Quality of life (QOL) is defined as “individual percep-
tion of their position in life, in relation to their goals, 
expectation, standards and concerns”. QOL incorpo-
rates patient’s perspective of his/her physical/men-
tal/social wellbeing. QOL is a powerful tool to predict 
an individual’s capacity to manage the disease and 
maintain long term health and well-being.[6] 
QOL assessment is considered as important measure 
of outcome in chronic disease management. It also 
represents the ultimate goal of all health interven-
tions.[7] Routine assessment of QOL as a part of clini-
cal practice has the potential to improve communica-
tion between patient and the health care provider, 
identify frequently overlooked problems and assess 
them.[8] The framework of QOL is based on under-
standing of an individual’s well-being. QOL is meas-
ured in terms of objective and subjective indicators: 
objective QOL includes finance, employment, educa-
tion and social or physical environment; subjective 
QOL includes personal opinion, emotional and physi-
cal well-being.[9]  
WHOQOL-BREF SCALE 
The WHOQOL-BREF is a 26-item instrument consist-
ing of four domains: physical health (7 items), psy-
chological health (6 items), social relationships (3 
items), and environmental health (8 items); it also 
contains QOL and general health items. Each individ-
ual item of the WHOQOL-BREF is scored from 1 to 5 
on a response scale, which is stipulated as a five point 
ordinal scale. The scores are then transformed line-
arly to a 0–100 scale, where 100 is the highest QOL 
and 0 is the lowest QOL. The mean score of each do-
main and the total score were calculated.[10] 
The physical health domain includes items on mobil-
ity, daily activities, functional capacity, energy, pain, 
and sleep. The psychological domain measures in-
clude self-image, negative thoughts, positive atti-
tudes, self-esteem, mentality, learning ability, 
memory concentration, religion, and mental status. 
The social relationships domain contains questions 
on personal relationships, social support, and sex life. 
The environmental health domain covers issues re-
lated to financial resources, safety, health and social 
services, living physical environment, opportunities 
to acquire new skills and knowledge, recreation, gen-
eral environment.[11] 
MATERIALS & METHODOLOGY 
Objectives: The main objective of the study is to 
measure the impact of microvascular complications 
and to assess the effect of patient counselling in im-
proving their quality of life in diabetic patients.  
Study site: The present study was conducted in ter-
tiary care hospital, Chalmeda Ananda Rao institute of 
medical science, Karimnagar, Telangana.  
Study period: 6 months 
Study criteria: All patients who have diagnosed with 
diabetes mellitus  
Inclusion criteria: All patients with diabetes irre-
spective of gender 
Exclusion criteria: Critically ill patients who are not 
in a position to be interviewed, pregnant women can-
cer patients, psychiatric patients were excluded from 
the study.  
Study procedure: The study was conducted in mul-
tiple departments of Chalmeda Ananda Rao institute 
of medical science. The data like demographic details, 
comorbidities, past medication history and medical 
history were obtained by direct patient interview, re-
view of patient medical records and documented in 
the data collection forms designed for study. The QOL 
of each patient was assess by using WHO-BREF ques-
tionnaire. It consists of 26 questions and 4 domains 
as discussed above. Each individual item of WHO-
BREF is scored from 1 to 5 on a response scale. The 
row scores for the domains were calculated by adding 
values of single items and were transformed on the 
scale ranging from 0 to 100, where 100 is the highest 
and 0 is the lowest QOL. 
Statistical analysis: Data analysis was carried out 
using Microsoft excel 2001 version. Statistics was ap-
plied using graph pad prism 8 and the correlation be-
tween the complications and quality of life was ana-
lysed by using Pearson’s correlation co-efficient. 
RESULTS & DISCUSSION  
Data was collected from a total of 140 diabetic pa-
tients of the age distribution 10 to 88 years with a 
mean age of 55.56 years (Mean age ±SD 
55.56±18.38). 97(69.28%) were male with mean age 
of 55.52±9.89yr and 43 (30.71%) were female with 
mean age of 55.65±3.53years. 
 
Figure 1: Age distribution of diabetic patients by gen-
der 






Male (%) Female (%) 
10-19 5 (3.57%) 3 (3.09%) 2 (4.65%) 
20-29 4 (2.85%) 2 (2.06%) 2 (4.65%) 
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30-39 9 (6.42%) 8 (8.24%) 1(2.32%) 
40-49 22 (15.71%) 16 (16.49%) 6 (13.95%) 
50-59 31 (22.14%) 21 (21.64%) 10 (23.25%) 
60-69 47 (33.57%) 33 (34.02%) 14 (32.55%) 
70-79 16 (11.42%) 9 (9.27%) 7 (16.27%) 
80-89 6 (4.28%) 5 (5.15%) 1 (2.32%) 
Total 140 97 43 
Education distribution: Among the study partici-
pants majority of them are illiterate (53%), and lit-
erate (24%), the rest of them completed at least their 
primary and secondary (4%) education. 
Table 2: Education distribution by number of patients 
Education No. of patients Percentage (%) 
Illiterate 83 59% 
Literate 33 24% 
Primary 18 13% 
Secondary 6 4% 
 
Figure 2: Education distribution by number of patients 
Among 140 patients, 100 were diagnosed with differ-
ent complications and 40 without complications. 
 
Figure 3: Complications Chart 
Among 100 patients 67 (67%) were diagnosed with 
nephropathy, of which 50(74.62%) were males, 17 
(25.37%) were females. 5(5%) patients were diag-
nosed with retinopathy, of which 4 (80%) were 
males, 1(20%) were females. 18(18%) patients were 
diagnosed with foot ulcers, of which 12 (66.66%) 
were males, 6(33.33%) were females.7(7%) patients 
were diagnosed with DKA, of which 3(42. 85%) were 
males, 4 (57.14%) were females. 3(3%) patients were 
diagnosed with neuropathy, of which 3 (100%) were 
males. 
 
Figure 4: Distribution of patients by type of complica-
tions 
Table 3: Distribution of patients by type of complica-
tions 
Complications Male Females 
Nephropathy 50 17 
Retinopathy 4 1 
DKA 3 4 
Neuropathy 3 0 
Foot ulcers 12 6 
In this study among 140 patients, 64 (45.7%) patients 
were satisfied, of which males were 41(64.06%) and 
females were 23(35.93%). and 76(54.2%) patients 
were dissatisfied, of which males were 56(73.68%) 
and females were 20(26.31%). 
Table 4: No of patients satisfied and dissatisfied based 
on WHOQOL-BREF Score 
 Satisfied Dissatisfied 
Complications 46 54 
Without complications 23 17 
 
Figure 5: No of patients satisfied and dissatisfied 
based on WHOQOL-BREF Score 
In total, 140 participants were interviewed with 
WHOQOL-BREF questionnaire. Of this male were 
97(69.2%) with a mean age of 55.52±9.8994.and fe-
males were 43(30.71%) with a mean age of 
55.65±3.5355. The mean of different domains was 
found to be DOM1- 52.671±26.87, DOM2-
49.70±4.242, DOM3- 52.31±26.16, DOM4- 
49.76±4.94. The highest mean score was found for 
DOM1 Physical health (52.67), Implying good activi-
ties of daily living, less dependence on medicinal sub-
stances and medical aids, enough energy and mobil-
ity, less pain and discomfort, sufficient sleep, rest and 
good work capacity. And lowest mean score for 
DOM2 Psychological health (49.70), Indicating not 
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very much bodily appearance, negative feelings, per-
sonal beliefs, thinking, learning, memory and concen-
tration.  
The mean scores were slightly lower for all the do-
mains in diabetic patients with complications com-
pared with the controls without complications. The 
Pearson’s correlation co-efficient was used to deter-
mine the level of agreement between diabetes with 
complications and without complications (r = -
0.1168). We used single t-test for comparison of 
mean scores values for the domains of the WHOQOL-
BREF and the significant difference between four do-
mains is found to be p<0.001. 










Nephropathy 51.59 50 53.84 49.66 
Neuropathy 52.52 54.19 56.68 48.83 
Foot ulcers 51.38 53.16 55.5 47.61 
DKA 56.42 55.42 58 54.42 
Retinopathy 37.6 48.6 58.8 46.4 
Without com-
plications 
55 48.62 52.05 54.5 
 
Figure 6: Domain wise mean in different complica-
tions 
CONCLUSION  
This study has shown that diabetic complications 
particularly nephropathy, have a profound impact on 
the quality of life of patients with type 2 diabetes 
mellitus. Even the presence of mild diabetic compli-
cations has a significant impact on the QOL. In this 
study WHOQOL- BREF questionnaire is used to know 
the impact of microvascular complications on quality 
of life in diabetic patients. 
Participants with older age, male gender of diabetes 
Mellitus worse their quality of life. Diabetic patients 
with complications are not satisfied with their QOL 
compared with diabetic patients without complica-
tions. To improve QOL in patients with type 2 diabe-
tes, early diagnosis of the disease and aggressive 
management of risk factors, counselling and educa-
tion regarding the disease are necessary to prevent 
the development of diabetic complications and ensu-
ing improvement of QOL. 
With the emergence of non-communicable diseases 
in developing countries, health care professionals 
should make use of opportunities in educating people 
with diabetes mellitus to promote a good quality of 
life. 
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